Editorial
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Dec 15, 2023; 15(12): 2049-2052
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2049
Dual primary gastric and colorectal cancer: A complex challenge in surgical oncology
Luigi Marano
Luigi Marano, Medical Department, Academy of Applied Medical and Social Sciences - Akademia Medycznych i Społecznych Nauk Stosowanych, Elbląg 82-300, Poland
Author contributions: Marano L designed the overall concept and outline of the manuscript, wrote and edited the manuscript and review of literature.
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Luigi Marano, MD, PhD, Professor, Medical Department, Academy of Applied Medical and Social Sciences - Akademia Medycznych i Społecznych Nauk Stosowanych, Lotnicza 2, Elbląg 82-300, Poland. l.marano@amisns.edu.pl
Received: October 17, 2023
Peer-review started: October 17, 2023
First decision: November 1, 2023
Revised: November 1, 2023
Accepted: November 17, 2023
Article in press: November 17, 2023
Published online: December 15, 2023
Core Tip

Core Tip: This editorial explores the complex landscape of dual primary gastric and colorectal cancer (DPGCC), investigating synchronous and metachronous cases. It uncovers a clear prognostic gap, emphasizing the need of early detection. The research underlines the pivotal role of surgical interventions, with gastric cancer stage significantly impacting patient outcomes. It also highlights the need for regular follow-up due to the majority of second primary cancers occurring within five years. The current literature provides guidance for individualized therapeutic approaches, enhancing patient prognoses, and underscores the intricate and multifaceted character of managing DPGCC.